Nexus between corporate governance disclosure and firm performance
Md. Nazrul Islam ORCID ↗ · Syed Zabid Hossain · Md. Sayaduzzaman
International Journal of Research in Business and Social Science · 2024 · Vol. 13 / Issue 1 · 303-313
Publication metrics
External links open provider records or DOI searches. Provider counts are not combined. Mendeley readership measures saves, not citations.
Dimensions
Live provider badge. If unavailable, use the Dimensions link above.
Observed 21 Oct 2026, 07:22 UTC
Observed 21 Oct 2026 07:22 UTC
OpenAlex and Mendeley observations refresh on article visits, at most once per 24 hours. Unavailable data is not zero. Google Scholar opens a DOI search.
Citations received by this article, grouped by the year of the citing work. Crossref and OpenAlex lifetime totals remain separate in Publication metrics.
2017–2026 Annual history last updated:
Citations received
OpenAlex · year of the citing work
Hover over a year or focus the chart and use arrow keys to inspect values.
2017–2026 annual-history window. 2026 is year to date. Unknown years have gaps.
View data & coverage
2026 is incomplete. Within a successfully fetched ten-year window, omitted years mean zero. Years beyond a saved observation’s window remain unknown (—). Older citations are excluded, so this chart’s sum may differ from the OpenAlex lifetime total. The date above belongs to this annual history; an unsuccessful refresh keeps the previous observation.
Abstract
The paper intended to evaluate the extent of corporate disclosure compliance and its effect on the financial performance of Bangladeshi pharmaceutical companies listed on the DSE during a twelve-year period, from 2007 to 2020. The study explored the affinity between the Corporate Governance Disclosure Index (CGDI) and firm financial performance employing econometric techniques, such as fixed effect and random effect models. The study calculated the disclosure scores as a percentage of a given firm's overall score to the probable score it could achieve. The CGDI of the sample companies showed a positive and substantial effect on company performance as an accounting measure ROA and an insignificant effect as a market measure Tobin’s Q. The study also revealed that sample firms followed the BSEC guidelines partially. These findings have implications for companies that fail to comply with the full disclosure principle, which holds that a company must disclose all material information in its financial statements in order to touch the reader's comprehension of those statements. In addition, these results imply that the code of CG requires a thorough examination to make essential modifications.
Keywords: {'name': 'Corporate governance, Corporate disclosure, Firm performance, Pharmaceutical companies, Bangladesh'}
Authors & affiliations
Md. Nazrul Islam
Affiliation not supplied
Syed Zabid Hossain
Affiliation not supplied
Md. Sayaduzzaman
Affiliation not supplied
Deposited references
Supplied references, not a list of publications citing this article.
DOI: 10.1016/j.brq.2017.04.001
DOI: 10.2139/ssrn.3322063
DOI: 10.1007/s10668-022-02853-y
DOI: 10.1016/j.ribaf.2019.101083
Ammari, A., Ayed, N. B., & Ellouze, A. (2016). The interaction between Board Independence and CEO entrenchment on Tobin’s Q. International Journal of Business & Economic Strategy, 4(1), 1-13.
DOI: 10.12775/CJFA.2020.005
DOI: 10.13106/jafeb.2017.vol4.no3.5
Barako, D. G., Hancock, P., & Izan, I. (2006). Relationship between corporate governance attributes and voluntary disclosures in annual reports: The Kenyan experience. FRRaG (Financial Reporting, Regulation and Governance), 5(1), 1-26. http://www.business.curtin.edu.au/business/research/journals-ublishedbycbs/financial-reporting-regulation-and-governance
DOI: 10.2139/ssrn.3881065
Ben P.J. (2014). Corporate governance index and firm performance. Journal of Contemporary Research in Management, 9(3), 33–44.
DOI: 10.1093/jleo/ewj018
DOI: 10.14453/aabfj.v11i1.6
DOI: 10.2139/ssrn.982615
DOI: 10.1016/j.jaccpubpol.2010.02.001
DOI: 10.1177/104225879301700305
DOI: 10.1108/SRJ-01-2017-0005
DOI: 10.3390/jrfm11030050
DOI: 10.1108/CG-05-2016-0100
DOI: 10.1016/j.ribaf.2016.07.019
El-Gazzar, S. M., & Fornaro, J. M. (2003). An Empirical Investigation of Corporate Voluntary Disclosure of Management's Responsibilities for Financial Reporting, Lubin School of Business Faculty [Working Papers], Pace University. https://digitalcommons.pace.edu/lubinfaculty_workingpapers/46
DOI: 10.1002/smj.3313
George, D., & Mallery, M. (2010). SPSS for Windows Step by Step: A Simple Guide and Reference, 17.0 update (10a ed.) Boston: Pearson.
DOI: 10.2307/2491219
DOI: 10.1162/00335530360535162
Gupta, A., Nair, A. P., & Gogula, R. (2003). “Corporate Governance Reporting by Indian Companies: A Content Analysis Study.” The ICFAI Journal of Corporate Governance, 2(4), 7-18.
Hagberg, C., Johansson, S., & Karlsson, A. (2015). The relationship between CSR and financial performance: A quantitative study examining Swedish publicly traded companies. [Master Thesis, Linnaeus University]. https://www.diva-portal.org/smash/get/ diva2:839031/FULLTEXT01.pdf
DOI: 10.1111/1467-6281.00112
DOI: 10.5605/IEB.9.5
Hasan, M. S., Hossain, S. Z., & Swieringa, R. J. (2013). Corporate governance and financial disclosures: Bangladesh perspective. Corporate Governance, 4(1), 109-119.
DOI: 10.5605/IEB.12.2
DOI: 10.2307/1913827
DOI: 10.1016/S0165-4101(01)00018-0
DOI: 10.30585/jrems.v3i3.674
DOI: 10.1111/1475-679X.00102
Islam, M. N. (2023). The Effect of Ownership Structure on Financial Performance of Bangladeshi Listed Pharmaceutical Companies. The Cost and Management, 51(4), 27-39.
DOI: 10.5296/jpag.v5i2.7498
DOI: 10.1016/S0304-405X(00)00069-6
DOI: 10.1016/S0929-1199(03)00046-4
DOI: 10.1080/14631370802018973
DOI: 10.2991/icastss-19.2019.66
DOI: 10.1108/14720700810879187
DOI: 10.1080/16081625.2001.10510584
DOI: 10.2139/ssrn.218490
DOI: 10.1504/IJEA.2017.084876
DOI: 10.4236/tel.2017.77139
DOI: 10.1016/j.iref.2014.11.022
DOI: 10.1108/CG-12-2020-0535
DOI: 10.1016/S2212-5671(16)00016-2
DOI: 10.1016/j.cpa.2014.10.004
DOI: 10.2139/ssrn.572504
DOI: 10.1002/jae.951
DOI: 10.1016/j.jeconom.2007.05.010
DOI: 10.13106/jafeb.2018.vol5.no2.53
Rahman, W. (2012). Pharmaceutical industry: Progress and challenges. The Daily Star, Retrieved on April 29, 2021, from https://www.thedailystar.net/news-detail-239204.
DOI: 10.3390/su15097206
DOI: 10.1016/j.fbj.2017.11.003
DOI: 10.1016/j.emj.2016.03.003
DOI: 10.1108/JAEE-10-2021-0320
Rouf, M. A. (2012). The financial performance and corporate governance disclosure: A study in the annual reports of listed companies of Bangladesh. Pakistan Journal of Commerce and Social Science, 6(1), 1-11. https://ssrn.com/abstract=2568478
DOI: 10.2139/ssrn.2055091
DOI: 10.1108/JFRA-03-2020-0079
DOI: 10.1057/jdg.2015.2
DOI: 10.1016/j.jclepro.2019.04.027
DOI: 10.1108/IMEFM-06-2020-0269
Tomar, S. and Bino, A., (2012). Corporate Governance and Bank Performance: Evidence from Jordanian Banking Industry. Jordan Journal of Business Administration, 8(2), 353-372.
DOI: 10.3934/GF.2020006
World Bank Report (2019). Retrieved on April 29, 2021, from https://data.worldbank.org/indicator/NY.GDP.MKTP.KD.ZG?locations=BD
DOI: 10.3390/su12041446
Xie, X. and Ward, P. (2019). The Impact of Corporate Social Responsibilities on Financial Performance in China. Master’s thesis, Duke University, Durham, NC, USA.
DOI: 10.3390/su14106237